Cartography Biosciences partners with Pfizer to discover tumour-selective antigens

Nimbus Therapeutics partners with Lilly to develop oral obesity treatment

BioArctic and Eisai secure Chinese acceptance for subcutaneous Leqembi filing

Oculis secures FDA Breakthrough Therapy Designation for Privosegtor in optic neuritis

Nanjing Delova Biotech reports positive Phase 3 trial results for QP-6211 for postoperative pain

MetaVia reports positive results from Phase 1 clinical trial in obesity

RedHill advances RHB-102 across GI indications

Halozyme licenses ENHANZE to Skye Bioscience for nimacimab obesity programme

Kelun-Biotech lung cancer drug granted Breakthrough Therapy Designation in China

BioInvent reports encouraging Phase 2a data for BI-1808 plus pembrolizumab in recurrent ovarian cancer

FDA grants priority review for Sanofi's Tzield in young children with stage 2 type 1 diabetes

GSK secures China approval for Nucala in COPD

Insilico Medicine signs multi-year research and development collaboration with Servier

WuXi Biologics achieves ISO 20400 Sustainable Procurement certification

ChemPartner updates its visual identity and digital experience